Skip to content

Stress Management for Irritable Bowel Syndrome

Stress Management for Irritable Bowel Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01886027
Enrollment
106
Registered
2013-06-25
Start date
2013-06-30
Completion date
2015-03-31
Last updated
2015-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

IBS, Relaxation, Emotional exposure, Emotional Processing

Brief summary

The primary goal of this study is to test the efficacy of emotional awareness and expression training (EAET), a novel emotional processing intervention that the investigators have developed, for people with IBS. In this randomized, controlled trial, the investigators will compare EAET to a standard intervention that teaches the conceptually opposite approach-relaxation training (RT)-and test how both of these interventions compare to a wait-list control condition. The investigators hypothesize that individuals in the EAET group will demonstrate greater improvement in their IBS symptom severity, psychological functioning, quality of life, and health care utilization at 4 and 12-week follow-up time points, compared to individuals in the wait-list control group. It is also expected that both of the active interventions (EAET and RT) will be more efficacious than the wait-list control condition.

Interventions

BEHAVIORALEmotional Awareness and Expression Training

An emotional processing intervention, which aims to reduce stress by helping patients become aware of, and express emotions related to stressful life experiences, as well as teaching patients how to relate to others differently.

BEHAVIORALRelaxation Training

Teaches patients different relaxation training skills to reduce their distress and discomfort (i.e., progressive muscle relaxation, applied relaxation, or guided imagery.

Sponsors

Wayne State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

To be eligible to participate, individuals must meet the Rome III criteria for IBS. That is, they must report that they have had: * recurrent abdominal pain or discomfort, or * a change in stool frequency or form, * at least three days per month, in the last three months, and * that they have been given this diagnosis by a physician. They must also report having pain and discomfort of at least two days per week at time of screening.

Exclusion criteria

* Individuals who report having post-infectious IBS, * organic gastrointestinal diseases (e.g., inflammatory bowel disease), immunodeficiency, * a current psychotic disorder, * drug or alcohol dependence within the past two years, and * those who are unable to communicate in English will be excluded.

Design outcomes

Primary

MeasureTime frame
IBS symptom severity scale (IBS-SSS)Change from baseline symptom severity at 1 month and 3 months

Secondary

MeasureTime frame
Ambivalence over Emotional Expression Scale (AEQ)Change from baseline ambivalence over emotional expression at 1 month and 3 months
Positive and Negative Affect Scale (PANAS)Change from baseline positive affect and negative affect at 1 month and 3 months
Impact of Events Scale - Revised (IES-R)Change from baseline impact of events at 1 month and 3 months
Toronto Alexithymia Scale -20 (TAS-20)Change from baseline alexithymia at 1 month and 3 months
McGill Pain Questionnaire, Short Form (SF-MPQ-2)Change from baseline pain at 1 month and 3 months
Bristol Stool Form Scale (BSFS)Change from baseline stool form at 1 month and 3 months
Irritable Bowel Syndrome, Quality of Life (IBS-QOL)Change from baseline quality of life at 1 month and 3 months
Rathus Assertiveness Schedule (RAS)Change from baseline assertiveness at 1 month and 3 months
Emotional Approach Coping Scale (EAC)Change from baseline emotional approach coping at 1 month and 3 months
Communicating Thoughts and Feelings QuestionnaireChange from baseline ability to communicate thoughts and feelings at 1 month and 3 months
Clinical Global Impressions (CGI) Improvement Scale - IBS versionChange from baseline IBS symptoms at 1 month and 3 months
Health care Utilization ScaleChange in health care utilization from baseline to 1-month and 3-month follow-ups
Brief Symptom InventoryChange in psychological symptoms from baseline to 1-month and 3-month follow-ups
Early Trauma Inventory Self-Report Short FormChange in Trauma reports from baseline to 1-month and 3-month follow-ups
Experiences in Close Relationships QuestionnaireChange in attachment from baseline to 1-month and3-month follow-ups
General Social Constraints ScaleChange in social constraints from baseline to 1-month and 3-month follow-ups
Medication useChange in medication use from baseline to 1-month and 3-month follow-ups
IBS self-efficacy questionnaireChange from baseline self-efficacy at 1 month and 3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026